Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed mean body weight reductions of approximately 24% at 48 weeks with the highest dose, with no clear plateau observed
approval for retatrutide in obesity would likely be in late 2027 or 2028 , though an accelerated pathway is possible if the totality of evidence is sufficiently compelling
It not only summarizes the mechanism of early prevention and treatment of NAFLD, but also provides reference ideas for the development of TCM for the treatment of metabolic diseases and liver diseases
Alcohol use was measured through Timeline Follow Back (TLFB)
Researchers are currently recruiting participants for a phase 3 trial that aims to verify these results
Because of this, individuals supplementing this form of B12 often report improved quality of sleep, often will require slightly less sleep, and will not uncommonly report that they feel a bit more refreshed when waking in the morning